CB2 Insights Inc News - CBII

Empower your portfolio: Real-time discussions and actionable trading ideas.

Premium

CB2 Insights Launches Industry’s First Medical Cannabis Insights Dashboard for All Medical Cannabis Stakeholders

TORONTO, March 30, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights Appoints Healthcare Industry Expert and Former IQVIA Executive Tom Brogan to its Board of Directors

TORONTO, Jan. 29, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights Announces Completion of Payment of New Jersey Alternative Medicine

TORONTO, Jan. 27, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights Selected by Vireo Health to Support Medical Cannabis Clinical Trial

Partnership Underway to Develop Extensive Protocols and Submissions for US Food & Drug Administration to...

CB2 Insights 2019 Year In Review – A Message from CEO and Co-Founder Pradyum Sekar

TORONTO, Jan. 08, 2020 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights Announces Industry's First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Brands

CB2 Insights Announces Industry’s First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Brands (Formerly...

CB2 Insights Announces Industry’s First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Br...

Prospective trial marks first-of-its-kind study on the efficacy and safety of hemp-based CBD treatment focused...

CB2 Insights Completes Full-Scale Platform to Connect Disparate Data Systems

Licensed Producers and Multi-State Operators are recognizing the volumes of data they hold from production...

CB2 Insights Launches Warrant Incentive Program

TORONTO, Dec. 11, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia

TORONTO, Dec. 03, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights to Participate at Piper Jaffray’s 31st Annual Healthcare Conference

TORONTO, Nov. 14, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019; Sequential Growth of 29%

TORONTO, Nov. 08, 2019 (GLOBE NEWSWIRE) -- CB2 Insights (CSE:CBII; OTCQB: CBIIF) (“CB2” or the “Company”), a...

CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call

CB2 Insights’ Q3 2019 preliminary unaudited revenue saw a sequential growth of approximately 29% compared to...

VIVO and CB2 Insights Enter Technology and Research Partnership

Partnership to focus on implementing a medical product development strategy for VIVO’s global medical cannabis...

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CB2 Insights Inc (CBII)

Empower your portfolio: Real-time discussions and actionable trading ideas.

CBII News

CB2 Insights Launches Industry’s First Medical Cannabis Insights Dashboard for All Medical Cannabis Stakeholders

CB2 Insights Appoints Healthcare Industry Expert and Former IQVIA Executive Tom Brogan to its Board of Directors

CB2 Insights Announces Completion of Payment of New Jersey Alternative Medicine

CB2 Insights Selected by Vireo Health to Support Medical Cannabis Clinical Trial

CB2 Insights 2019 Year In Review – A Message from CEO and Co-Founder Pradyum Sekar

CB2 Insights Announces Industry's First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Brands

CB2 Insights Announces Industry’s First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Br...

CB2 Insights Completes Full-Scale Platform to Connect Disparate Data Systems

CB2 Insights Launches Warrant Incentive Program

CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia

CB2 Insights to Participate at Piper Jaffray’s 31st Annual Healthcare Conference

CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019; Sequential Growth of 29%

CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call

VIVO and CB2 Insights Enter Technology and Research Partnership

CBII Discussion

Your Recent History

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover

CB2 Insights Inc (CBII) News

CB2 Insights Inc (CBII)

Empower your portfolio: Real-time discussions and actionable trading ideas.

CBII News

CB2 Insights Launches Industry’s First Medical Cannabis Insights Dashboard for All Medical Cannabis Stakeholders

CB2 Insights Appoints Healthcare Industry Expert and Former IQVIA Executive Tom Brogan to its Board of Directors

CB2 Insights Announces Completion of Payment of New Jersey Alternative Medicine

CB2 Insights Selected by Vireo Health to Support Medical Cannabis Clinical Trial

CB2 Insights 2019 Year In Review – A Message from CEO and Co-Founder Pradyum Sekar

CB2 Insights Announces Industry's First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Brands

CB2 Insights Announces Industry’s First Full-Scale Hemp-based Cannabidiol (CBD) Prospective Trial in Partnership with GL Br...

CB2 Insights Completes Full-Scale Platform to Connect Disparate Data Systems

CB2 Insights Launches Warrant Incentive Program

CB2 Insights Announces Collaboration with FCM Global to Support Medical Cannabis R&D in Colombia

CB2 Insights to Participate at Piper Jaffray’s 31st Annual Healthcare Conference

CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019; Sequential Growth of 29%

CB2 Insights Announces Record Preliminary Unaudited Q3 2019 Revenue of $4.2 Million and Details for Earnings Call

VIVO and CB2 Insights Enter Technology and Research Partnership

CBII Discussion

Your Recent History